Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition

The activated hepatic stellate cell (HSC) is central to liver fibrosis as the major source of collagens I and III and the tissue inhibitors of metalloproteinase-1 (TIMP-1). During spontaneous recovery from liver fibrosis, there is a decrease of TIMP expression, an increase in collagenase activity, and increased apoptosis of HSC, highlighting a potential role for TIMP-1 in HSC survival. In this report, we use tissue culture and in vivomodels to demonstrate that TIMP-1 directly inhibits HSC apoptosis. TIMP-1 demonstrated a consistent, significant, and dose-dependent antiapoptotic effect for HSC activated in tissue culture and stimulated to undergo apoptosis by serum deprivation, cycloheximide exposure, and nerve growth factor stimulation. A nonfunctional mutated TIMP-1 (T2G mutant) in which all other domains are conserved did not inhibit apoptosis, indicating that inhibition of apoptosis was mediated through MMP inhibition. Synthetic MMP inhibitors also inhibited HSC apoptosis. Studies of experimental liver cirrhosis demonstrated that persistent expression of TIMP-1 mRNA determined by PCR correlated with persistence of activated HSC quantified by α smooth muscle actin staining, while in fibrosis, loss of activated HSC correlated with a reduction in TIMP-1 mRNA. We conclude that TIMP-1 inhibits apoptosis of activated HSC via MMP inhibition.

[1]  R. Boulton,et al.  Assessing cell proliferation: a methodological review. , 1995, Clinical science.

[2]  A. H. Drummond,et al.  Fas ligand in human serum , 1996, Nature Medicine.

[3]  G. Ramadori,et al.  Transforming growth factor β and tumor necrosis factor α inhibit both apoptosis and proliferation of activated rat hepatic stellate cells , 1999 .

[4]  Wen-rong Gong,et al.  Transformation‐dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble fas ligand , 1998, Hepatology.

[5]  A. Gressner,et al.  Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. , 1992, The Journal of clinical investigation.

[6]  M. Solioz,et al.  False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate. , 1998, Molecular pathology : MP.

[7]  J. Iredale,et al.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. , 1998, The Journal of clinical investigation.

[8]  H. Stein,et al.  Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver , 1991, Virchows Archiv. B, Cell pathology including molecular pathology.

[9]  G. Li,et al.  Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. , 1999, Cancer research.

[10]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[11]  J. Iredale,et al.  Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors , 2001, Gut.

[12]  H. Erdjument-Bromage,et al.  Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. , 1999, The Journal of clinical investigation.

[13]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[14]  S. Friedman,et al.  Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Thorgeirsson,et al.  Tissue inhibitor of metalloproteinases‐1 promotes liver fibrosis development in a transgenic mouse model , 2000, Hepatology.

[16]  W. Stetler-Stevenson,et al.  In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. , 1998, The Journal of clinical investigation.

[17]  M. Furue,et al.  Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts. , 1997, The Journal of investigative dermatology.

[18]  J. Iredale,et al.  Tissue inhibitor of metalloproteinase‐1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis , 1996, Hepatology.

[19]  P. Stephens,et al.  Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity , 1985, Nature.

[20]  N. Colburn,et al.  TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. , 1997, Cytokine.

[21]  J. Iredale,et al.  Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. , 1996, Gastroenterology.

[22]  J. Hughes,et al.  Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. , 1994, The Journal of clinical investigation.

[23]  J. Iredale,et al.  Tissue Inhibitor of Metalloproteinase-1 and Interstitial Collagenase Expression in Autoimmune Chronic Active Hepatitis and Activated Human Hepatic Lipocytes , 1995 .

[24]  S. Friedman.  The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies , 1993 .

[25]  A. Baker,et al.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. , 1998, The Journal of clinical investigation.

[26]  M. Lim,et al.  Tissue Inhibitor of Metalloproteinase‐2 Induces Apoptosis in Human T Lymphocytes , 1999, Annals of the New York Academy of Sciences.

[27]  S. Friedman,et al.  Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. , 1989, The Journal of clinical investigation.

[28]  R. F. McGuire,et al.  Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. , 1990, The Journal of clinical investigation.

[29]  R. Ross,et al.  Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. , 1998, Molecular biology of the cell.

[30]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[31]  K. Brew,et al.  Residue 2 of TIMP-1 Is a Major Determinant of Affinity and Specificity for Matrix Metalloproteinases but Effects of Substitutions Do Not Correlate with Those of the Corresponding P1′ Residue of Substrate* , 1999, The Journal of Biological Chemistry.

[32]  S. Afford,et al.  Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. , 2000, The American journal of pathology.

[33]  J. Nesland,et al.  High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  M. Cilli,et al.  TIMP‐2 over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis , 1998 .

[35]  G. Ramadori,et al.  CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. , 1997, The American journal of pathology.

[36]  J. Pober,et al.  Apoptosis-inducing Agents Cause Rapid Shedding of Tumor Necrosis Factor Receptor 1 (TNFR1) , 1999, The Journal of Biological Chemistry.

[37]  J. Iredale,et al.  Pathogenesis of liver fibrosis. , 1997, Clinical science.

[38]  J. Iredale,et al.  Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. , 2001, Gastroenterology.